28 results on '"Hudis, Clifford A"'
Search Results
2. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection
3. RESILIENCE: Phase III Randomized, Double-Blind Trial Comparing Sorafenib With Capecitabine Versus Placebo With Capecitabine in Locally Advanced or Metastatic HER2-Negative Breast Cancer
4. Adjuvant Chemotherapy and Trastuzumab Is Safe and Effective in Older Women With Small, Node-Negative, HER2-Positive Early-Stage Breast Cancer
5. Biomarkers That Predict Sensitivity to Heat Shock Protein 90 Inhibitors
6. A Pilot Study of Dose-Dense Paclitaxel With Trastuzumab and Lapatinib for Node-negative HER2-Overexpressed Breast Cancer
7. A Phase II Open-Label Study of Ganetespib, a Novel Heat Shock Protein 90 Inhibitor for Patients With Metastatic Breast Cancer
8. Randomized Phase II Trial of Weekly vs. Every 2 Weeks vs. Every 3 Weeks Nanoparticle Albumin-Bound Paclitaxel With Bevacizumab as First-Line Chemotherapy for Metastatic Breast Cancer
9. Phase II Trial of Saracatinib (AZD0530), an Oral SRC-inhibitor for the Treatment of Patients with Hormone Receptor-negative Metastatic Breast Cancer
10. Dose Dense Cyclophosphamide, Methotrexate, Fluorouracil is Feasible at 14-Day Intervals: A Pilot Study of Every-14-Day Dosing as Adjuvant Therapy for Breast Cancer
11. Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer
12. Intravenous Bisphosphonate Therapy Does Not Acutely Alter Nuclear Bone Scan Results
13. Phase I Study of Nonpegylated Liposomal Doxorubicin plus Trastuzumab in Patients with HER2-Positive Breast Cancer
14. Prolonged Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel in Breast Cancer Is Feasible
15. Insight into Barriers Against Optimal Adherence to Oral Hormonal Therapy in Women with Breast Cancer
16. Dose-Dense Therapy in the Treatment of Early-Stage Breast Cancer: An Overview of the Data
17. A Phase I Study of Cetuximab/Paclitaxel in Patients with Advanced-Stage Breast Cancer
18. Adjuvant Taxanes in the Treatment of Breast Cancer: No Longer at the Tip of the Iceberg
19. Weekly Epoetin Alfa During Adjuvant Chemotherapy for Breast Cancer: Effect on Hemoglobin Levels and Quality of Life
20. A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and Taxane
21. The Global Breast Cancer Burden: Variations in Epidemiology and Survival
22. Inadvertent Use of Aromatase Inhibitors in Patients with Breast Cancer with Residual Ovarian Function: Cases and Lessons
23. Effect of Cardiac Dysfunction on Treatment Outcomes in Women Receiving Trastuzumab for HER2-Overexpressing Metastatic Breast Cancer
24. Current Status and Future Directions in Breast Cancer Therapy
25. Adjuvant Use of Taxanes for Patients with Breast Cancer: We See the Tip of the Iceberg
26. Introduction
27. Dose-Dense Therapy in the Treatment of Early-Stage Breast Cancer: An Overview of the Data
28. A Phase II Trial of Gemcitabine in Patients with Metastatic Breast Cancer Previously Treated with an Anthracycline and Taxane
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.